17588568

Casper RF

2009

Letrozole versus clomiphene citrate: which is better for ovulation induction?

17590172

Savastano S

2007

Overexpression of the phosphoprotein enriched in diabetes gene product (Ped/pea-15) in women with polycystic ovary syndrome.

17592439

Setji TL

2007

Comprehensive clinical management of polycystic ovary syndrome.

17595241

Palomba S

2007

Clomiphene citrate versus metformin as first-line approach for the treatment of anovulation in infertile patients with polycystic ovary syndrome.

17596508

Bloomgarden ZT

2007

Gut hormones, obesity, polycystic ovarian syndrome, malignancy, and lipodystrophy syndromes.

17599257

Meyer-Bahlburg HF

2006

The Recalled Childhood Gender Questionnaire-Revised: a psychometric analysis in a sample of women with congenital adrenal hyperplasia.

17601419

Kraft JN

2007

Hidradenitis suppurativa in 64 female patients: retrospective study comparing oral antibiotics and antiandrogen therapy.

17601857

Barron ML

2007

Light exposure, melatonin secretion, and menstrual cycle parameters: an integrative review.

17601881

Devin JK

2007

Transgenic overexpression of plasminogen activator inhibitor-1 promotes the development of polycystic ovarian changes in female mice.

17601910

MacLaughlan SD

2007

Endometrial expression of Cyr61: a marker of estrogenic activity in normal and abnormal endometrium.

17602513

Matharoo-Ball B

2007

Characterization of biomarkers in polycystic ovary syndrome (PCOS) using multiple distinct proteomic platforms.

17603048

Lindholm A

2008

Effect of sibutramine on weight reduction in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.

17603706

Sharquie KE

2007

Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome.

17604615

Casper RF

2007

Aromatase inhibitors in ovarian stimulation.

17606307

Park HR

2007

Phenotypic characteristics according to insulin sensitivity in non-obese Korean women with polycystic ovary syndrome.

17606756

Raw DM

2007

Internal jugular vein thrombosis and ovarian hyperstimulation syndrome.

17609404

Orio F

2007

Metformin administration improves leukocyte count in women with polycystic ovary syndrome: a 6-month prospective study.

17610984

Park HR

2007

The metabolic syndrome in young Korean women with polycystic ovary syndrome.

17612537

Salih SM

2008

Regulation of catechol O-methyltransferase expression in granulosa cells: a potential role for follicular arrest in polycystic ovary syndrome.

17616856

Bik W

2007

The relationship between metabolic status and levels of adiponectin and ghrelin in lean women with polycystic ovary syndrome.

17618446

Gul OB

2008

The effect of ethinyl estradiol-cyproterone acetate treatment on homocysteine levels in women with polycystic ovary syndrome.

17624467

Carmina E

2007

Need for liver evaluation in polycystic ovary syndrome.

17625418

Menke MN

2007

Genetic approaches to polycystic ovarian syndrome.

17628554

Clapauch R

2008

Triplet pregnancy after metformin in a woman with polycystic ovary syndrome.

17629155

Check JH

2007

Ovulation disorders: Part II. Anovulation associated with normal estrogen.

17630601

Hassan A

2007

Polycystic ovary syndrome update in adolescence.

17635486

Siassakos D

2007

Polycystic ovary syndrome and pregnancy outcome: red herring or red flag?

17635847

Fulghesu AM

2007

Ultrasound in polycystic ovary syndrome--the measuring of ovarian stroma and relationship with circulating androgens: results of a multicentric study.

17636586

Hughes E

1996

WITHDRAWN: Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome.

17636588

Hughes E

1996

WITHDRAWN: Gonadotrophin-releasing hormone analogue as an adjunct to gonadotropin therapy for clomiphene-resistant polycystic ovarian syndrome.

17636653

Farquhar C

2007

Laparoscopic 'drilling' by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome.

17641850

Zhang J

2007

Apoptosis and expression of protein TRAIL in granulosa cells of rats with polycystic ovarian syndrome.

17643084

Styne DM

2007

The 4th International Congress on the Insulin Resistance Syndrome.

17644093

Manno M

2007

An important new adaption of a specific drug?

17644902

Mrazguia C

2007

[Effects of drilling on ovarian volume and follicle count in polycystic ovary syndrome].

17645376

Lee AT

2007

Dermatologic manifestations of polycystic ovary syndrome.

17651451

Kaltsas GA

2007

Polycystic ovaries and the polycystic ovary syndrome phenotype in women with active acromegaly.

17652213

Moran LJ

2007

The use of anti-mullerian hormone in predicting menstrual response after weight loss in overweight women with polycystic ovary syndrome.

17653882

Chen YC

2007

Serum resistin level is a predictor of ovarian response in in vitro fertilisation cycle.

17656598

M?hlig M

2007

Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women.

17656599

Hahn S

2007

Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism.

17658524

Lee EJ

2008

A novel single nucleotide polymorphism of INSR gene for polycystic ovary syndrome.

17658527

Romualdi D

2008

Metformin treatment does not affect total leptin levels and free leptin index in obese patients with polycystic ovary syndrome.

17659081

Kassab A

2007

Does measuring early basal serum follicular luteinising [correction of lutinising] hormone assist in predicting in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) outcome?

17659447

Dumesic DA

2007

Polycystic ovary syndrome and its developmental origins.

17659845

Barnard L

2007

Cognitive functioning in polycystic ovary syndrome.

17660597

Tokhunts KA

2007

[Comparative characteristics of clinical-laboratory data and echography monitoring of the processes of folliculogenesis at hyperandrogenia syndrome].

17661167

Karadeniz M

2007

4G/5G polymorphism of PAI-1 gene and Alu-repeat I/D polymorphism of TPA gene in Turkish patients with polycystic ovary syndrome.

17664244

Votruba SB

2007

Meal fatty acid uptake in visceral fat in women.

17664881

Al-Sunaidi M

2007

Age-related changes in antral follicle count among women with and without polycystic ovaries.

17666089

Sahin Y

2007

The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome.

17668731

Thaler CJ

2007

[Polycystic ovary syndrome (PCOS)].

17669713

Sharma ST

2007

Changes in glucose tolerance with metformin treatment in polycystic ovary syndrome: a retrospective analysis.

17673036

Chen ZJ

2007

[We should pay more attention to standardized diagnosis and treatment of polycystic ovary syndrome].

17673037

Yu Q

2007

[Synopsis of the second national seminar about developments in diagnosis and treatment of polycystic ovary syndrome and related diseases].

17673038

Ma LK

2007

[Effect of lifestyle adjustment, metformin and rosiglitazone in polycystic ovary syndrome].

17673039

Wang LN

2007

[Study on endometrium receptivity in patients with polycystic ovary syndrome during implantation window time].

17673040

Huang WJ

2007

[Analysis of environmental factors and polycystic ovary syndrome].

17678910

Glueck CJ

2008

Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome.

17679815

Khan KA

2006

Polycystic ovarian syndrome.

17681045

Toth B

2007

Peroxisome proliferator-activated receptors: new players in the field of reproduction.

17681319

Appasamy M

2008

Evaluation of the relationship between follicular fluid oxidative stress, ovarian hormones, and response to gonadotropin stimulation.

17681339

Mercorio F

2008

Evaluation of ovarian adhesion formation after laparoscopic ovarian drilling by second-look minilaparoscopy.

17684377

Blume-Peytavi U

2007

Unwanted facial hair: affects, effects and solutions.

17684456

Muneyyirci-Delale O

2007

Vascular compliance in women with polycystic ovary syndrome and healthy women.

17684622

Barcellos CR

2007

Prevalence of abnormalities of glucose metabolism in patients with polycystic ovary syndrome.

17686479

Badawy A

2008

Anastrozole or letrozole for ovulation induction in clomiphene-resistant women with polycystic ovarian syndrome: a prospective randomized trial.

17689311

Corley EA

2007

A use-and-transformation model for evaluating public R&D: illustrations from polycystic ovarian syndrome (PCOS) research.

17689477

Diamanti-Kandarakis E

2007

Metabolic syndrome: a contemporary fuel excess syndrome and its specific impact in women.

17692530

Diamanti-Kandarakis E

2007

Pathophysiology and types of dyslipidemia in PCOS.

17693095

Escobar-Morreale HF

2007

Abdominal adiposity and the polycystic ovary syndrome.

17698366

Teede HJ

2007

The management of insulin resistance in polycystic ovary syndrome.

17698904

Catteau-Jonard S

2007

Changes in serum anti-mullerian hormone level during low-dose recombinant follicular-stimulating hormone therapy for anovulation in polycystic ovary syndrome.

17698906

Stubbs SA

2007

Abnormal preantral folliculogenesis in polycystic ovaries is associated with increased granulosa cell division.

17701884

Cupisti S

2007

Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.

17705674

Vrb?kov? J

2008

Family history of diabetes mellitus determines insulin sensitivity and beta cell function in polycystic ovary syndrome.

17706206

Aroda V

2008

Circulating and cellular adiponectin in polycystic ovary syndrome: relationship to glucose tolerance and insulin action.

17706215

Hsu MI

2007

Diagnostic criteria for polycystic ovary syndrome in Taiwanese Chinese women: comparison between Rotterdam 2003 and NIH 1990.

17710731

Blank SK

2007

Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.

17710732

Sutton AL

2007

The pleiotropic effects of excessive luteinizing hormone secretion in transgenic mice.

17711149

Eggers S

2007

An evolutionary approach to explain the high frequency of the polycystic ovary syndrome (PCOS).

17711919

Wide L

2007

Sulfonation and sialylation of gonadotropins in women during the menstrual cycle, after menopause, and with polycystic ovarian syndrome and in men.

17714613

Rowe T

2007

Clomiphene citrate: an old favourite lives on.

17716857

Benson S

2008

Obesity, depression, and chronic low-grade inflammation in women with polycystic ovary syndrome.

17719609

Baba T

2007

Polycystic ovary syndrome is associated with genetic polymorphism in the insulin signaling gene IRS-1 but not ENPP1 in a Japanese population.

17720020

Norman RJ

2007

Polycystic ovary syndrome.

17724005

Diamanti-Kandarakis E

2007

Early onset adiposity: a pathway to polycystic ovary syndrome in adolescents?

17727172

Robyr D

2007

[Polycystic ovary syndrome and congenital adrenal hyperplasia: a different entity for comparable phenotypes?].

17727675

Franks S

2007

How good are we at diagnosing polycystic ovary syndrome?

17760884

Diamanti-Kandarakis E

2007

Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS.

17760885

Barth JH

2007

The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research.

17764855

Li Z

2008

Epigenetic abnormality: a possible mechanism underlying the fetal origin of polycystic ovary syndrome.

17766923

Trolle B

2007

Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial.

17767003

Moll E

2007

The role of metformin in polycystic ovary syndrome: a systematic review.

17767338

Ho FL

2007

Oral hypoglycaemic agents for diabetes in pregnancy - an appraisal of the current evidence for oral anti-diabetic drug use in pregnancy.

17785124

Tariq N

2007

Clinical diagnosis of polycystic ovarian syndrome and response to metformin therapy.

17785360

Pasquali R

2007

17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.

17785364

Urbanek M

2007

Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype.

17803698

Glintborg D

2008

Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo-controlled study in polycystic ovary syndrome.

17803701

Giallauria F

2008

Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in young overweight women with polycystic ovary syndrome.